NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

The CATALINA Study

RecruitingN/A

Sponsor: Wim Janssens

Conditions: Chronic Obstructive Pulmonary Disease Exacerbation

Countries: Austria, Belgium, France, Germany, Italy, Netherlands, Slovenia, Spain

The CATALINA study is a prospective cohort study embedded within CICERO (Collaboration In COPD ExaceRbatiOns, a European Respiratory Society supported Clinical Research Collaboration), designed to collect standardised, longitudinal clinical data and biological samples in 20 centres across Europe and beyond.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* Age 18 years and older
* Established diagnosis of COPD by medical doctor (based on clinical history OR pulmonary function test with an FEV1/FVC \< 0.7)
* Current hospitalization with suspicion of an acute exacerbation of COPD (AECOPD)
* Inclusion within 48 hours post hospital admission
* Voluntary written informed consent of the participant or his/her representative obtained prior to any study procedure

Exclusion Criteria:

* Patients unwilling or unable to comply with study procedures
* Patients not requiring treatment with systemic corticosteroids, antibiotics or both as a minimum therapy for the index AECOPD
* Patients with a confirmed positive test result for COVID19, or those highly suspected based on clinical examination

Locations (22)

Linz, Austria
Vienna, Austria
Brussels, Belgium
Leuven, Belgium
Yvoir, Belgium
Lille, France
Paris, France
Großhansdorf, Germany
Itzehoe, Germany
Kiel, Germany
Marburg, Germany
Ferrara, Italy
Groningen, Netherlands
Maastricht, Netherlands
Golnik, Slovenia
Barcelona, Spain
Gothenburg, Sweden
Ankara, Turkey (Türkiye)
Leicester, United Kingdom
London, United Kingdom
London, United Kingdom
Oxford, United Kingdom